Cell-Specific Aptamers as Emerging Therapeutics
Aptamers are short nucleic acids that bind to defined targets with high affinity and specificity. The first aptamers have been selected about two decades ago by an in vitro process named SELEX (systematic evolution of ligands by exponential...
Saved in:
Main Authors: | Cindy Meyer, Ulrich Hahn, Andrea Rentmeister |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Journal of Nucleic Acids |
Online Access: | http://dx.doi.org/10.4061/2011/904750 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preparation of a Specific ssDNA Aptamer for Brevetoxin-2 Using SELEX
by: Rui-Yun Tian, et al.
Published: (2016-01-01) -
Aptamers as new promising entities for therapeutics: our experience from the neurological diseases
by: Macarena Hernández-Jiménez, et al.
Published: (2025-12-01) -
DeepAptamer: Advancing high-affinity aptamer discovery with a hybrid deep learning model
by: Xin Yang, et al.
Published: (2025-03-01) -
Aptamers: A Feasible Technology in Cancer Immunotherapy
by: M. M. Soldevilla, et al.
Published: (2016-01-01) -
Structure-based insights into fluorogenic RNA aptamers
by: Song Qianqian, et al.
Published: (2024-08-01)